Ildstad Suzanne's Form 4 filing
Tourmaline Bio, Inc. (TRML) · filed Jun 5, 2023
- Accession no.
- 0001209191-23-034287
- Filed
- Jun 5, 2023
- Trade date
- Jun 1-2, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $79.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ildstad SuzanneCIK 0001845822 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2023 | Common Stock | SSaleDisposed | −15,713 | $2.56 | −$40,225.28 | 2,805,682 | Direct | |
| Jun 2, 2023 | Common Stock | SSaleDisposed | −15,818 | $2.50 | −$39,545 | 2,789,864 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.